Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sequoia Makes $30+ Million Investment in China Cardiac Hospital Chain

publication date: Jan 12, 2017
Sequoia Capital China made a strategic investment in Hong Kong Asia Medical Center, an operator of Chinese hospitals that emphasize cardiology care. Although the size of the investment was not disclosed, it was described as being in the hundreds of millions RMB (each 100RMB equals $14.5 million). Altogether HKAMC has 3,000 beds with a flagship hospital in Hong Kong, plus cardiology hospitals in Wuhan, Xinjiang province and other cities. HKAMC plans to expand its hospitals in China and overseas, while its also improves its existing facilities. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital